# Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer

> **NCT03570476** · PHASE2 · TERMINATED · sponsor: **University of Washington** · enrollment: 2 (actual)

## Conditions studied

- Prostate Adenocarcinoma Without Neuroendocrine Differentiation
- Stage I Prostate Cancer AJCC v8
- Stage II Prostate Cancer AJCC v8
- Stage IIA Prostate Cancer AJCC v8
- Stage IIB Prostate Cancer AJCC v8
- Stage IIC Prostate Cancer AJCC v8

## Interventions

- **DRUG:** Olaparib
- **PROCEDURE:** Radical Prostatectomy

## Key facts

- **NCT ID:** NCT03570476
- **Lead sponsor:** University of Washington
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-09-11
- **Primary completion:** 2019-05-31
- **Final completion:** 2019-07-03
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Terminated due to slow accrual
- **Last updated:** 2020-09-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03570476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03570476, "Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03570476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*